GIANNELLI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.606
EU - Europa 1.359
AS - Asia 312
AF - Africa 22
OC - Oceania 1
Totale 4.300
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.599
RU - Federazione Russa 630
IE - Irlanda 217
SE - Svezia 182
SG - Singapore 114
IT - Italia 84
HK - Hong Kong 77
UA - Ucraina 72
FI - Finlandia 57
CN - Cina 52
DE - Germania 46
TR - Turchia 39
GB - Regno Unito 31
IN - India 27
CI - Costa d'Avorio 20
CH - Svizzera 15
FR - Francia 7
NL - Olanda 7
CA - Canada 6
BE - Belgio 4
CZ - Repubblica Ceca 2
JO - Giordania 2
NO - Norvegia 2
SC - Seychelles 2
AT - Austria 1
AU - Australia 1
KR - Corea 1
MX - Messico 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.300
Salva come PNG Salva come JPEG
Città #
Santa Clara 648
Fairfield 234
Chandler 219
Dublin 217
Ashburn 150
Woodbridge 116
Jacksonville 102
Cambridge 99
Singapore 88
Wilmington 87
Seattle 85
Houston 81
Ann Arbor 60
Princeton 56
Buffalo 50
Boardman 38
Boston 38
Izmir 38
Hong Kong 30
Mumbai 27
Altamura 26
Beijing 26
Lawrence 26
Medford 25
Abidjan 20
Shanghai 17
Norwalk 16
Bern 15
San Diego 13
Bremen 11
New York 11
Washington 11
Falls Church 10
Moscow 10
Hillsboro 8
Andover 6
Florence 5
Milan 5
Philadelphia 5
Salerno 5
Brussels 4
Los Angeles 4
Munich 4
Toronto 4
Auburn Hills 3
Casalecchio di Reno 3
Guangzhou 3
Kent 3
Laurel 3
Redmond 3
Brno 2
Dearborn 2
Frankfurt Am Main 2
London 2
Meppel 2
Old Bridge 2
Oslo 2
Padova 2
Tappahannock 2
Yubileyny 2
Bologna 1
Central 1
Civitanova Marche 1
Clifton 1
Genoa 1
Grevenbroich 1
Groningen 1
Helsinki 1
Livorno 1
Melbourne 1
Montréal 1
Mérida 1
Napanee 1
Paris 1
Qingdao 1
Rome 1
San Mateo 1
Sanayi 1
Seoul 1
Stanford 1
Verona 1
Vienna 1
Worcester 1
Totale 2.811
Salva come PNG Salva come JPEG
Nome #
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 140
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 130
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 121
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 116
Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection 114
Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment 113
T(14;18) translocation in chronic hepatitis C virus infection 112
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways 112
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. 107
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 105
Analysis of HCV persistence in patients with sustained virological response 105
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 102
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 99
Hepatitis C virus lymphotropism and possible pathogenetic implications 96
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 96
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis 94
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 93
Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications 90
Interstitial lung fibrosis in patients with hepatitis C virus infection 90
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 89
Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases 86
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 84
Is T(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 82
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 82
Is t(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 82
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 77
Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases 76
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 74
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 72
Interferon alfa + Ribavirin (RIBA) therapy for chronic hepatitis C (CHC) patients non responders to interferon alfa monotherapy 70
Bcl-2 Recombination and Overexpression in HCV-related Mixed Cryoglobulinemia Patients. 68
Effect of antiviral treatment on the prevalence of BCL-2 recombination in HCV infected patients 68
Infezione da HCV e disordini linfoproliferativi 68
Plasma PAF-AH biological activity decreases in patients with HCV chronic infection 66
BCL-2 recombination and overexpression in HCV-related mixed cryoglobulinemia patients. 66
Il virus dell'epatite C (HCV): l'infezione e la malattia 66
HCV infection in B-cell non-Hodgkin’s lymphoma. 62
Hepatitis C virus as a lymphotropic agent: Evidence and pathogenetic implications 61
Virological analysis of mixed infections by different HCV genotypes in patients with HCV related chronic liver disease 58
Regression of T(14;18) rearing B-cell clones following antiviral therapy in chronic HCV infection 57
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 55
Prevalenza della ricombinazione Bcl-2 in pazienti con crioglobulinemia mista HCV correlata complicata o meno da linfoma.. 54
Association between HCV infection and monoclonal gammopathy (MG): A putative role for genotype 2a? 54
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 52
T(14;18) translocation amd BCL-2 overexpression in HCV infection: effects of Interferon and Ribavirin treatment 51
Modifications of Plasma PAF-AH activity in Patients with Chronic HCV infection 50
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 49
Relevance of t(14;18) translocation in pathogenesis of HCV-related lymphoproliferative disorders. 48
Hepatitis-C virus-infection and monoclonal gammopathy (MG) - possible role of genotype 2A 47
Ruolo dell’infezione da HCV nella crioglobulinemia mista e nel linfoma maligno a cellule B: analisi virologica ed implicazioni patogenetiche 45
Infezione delle cellule linfatiche da parte del virus C dell’epatite: fatti e controversie 44
Impact of liver transplantation in HCV-related lymphoproliferative disorders. 43
Hepatitis C virus, Epstein-Barr virus and human Herpes virus-6 infection of lymphoid cell in B-cell non-Hodgkin’s lymphoma 43
Manifestazioni extraepatiche dell’infezione da HCV 41
Prevalence of monoclonal gammopathy (MG) in patients with chronic HCV infection 41
Prevalence of bcl-2 recombination in hepatitis C virus related mixed cryoglobulinemia with or without complicating B-cell lymphoma 40
Totale 4.306
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.854
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020339 0 0 0 0 46 57 53 58 43 37 37 8
2020/2021281 42 13 19 36 2 42 6 24 23 32 23 19
2021/2022336 2 45 5 16 10 6 9 19 13 5 68 138
2022/2023879 92 86 46 59 97 191 127 42 86 11 20 22
2023/2024281 13 39 63 20 32 47 10 34 7 0 6 10
2024/20251.594 74 241 151 354 774 0 0 0 0 0 0 0
Totale 4.306